Simplified storage and administration of new tablet formulation may provide greater freedom and independence for people with ...

Roche’s Evrysdi (risdiplam) tablets have been approved by the European Commission (EC) to treat spinal muscular atrophy (SMA) ...

Panelists discuss how disease progression despite treatment in older patients with spinal muscular atrophy (SMA) may be due to natural aging effects combined with SMA, not necessarily treatment ...

European Commission approves Roche’s Evrysdi tablet to treat spinal muscular atrophy: Basel Thursday, June 5, 2025, 09:00 Hrs [IST] Roche announced that the European Commission ...

Already offering the only non-invasive treatment for SMA in liquid form, Roche’s Evrysdi now comes as a tablet.

dvm360 connects veterinarians to essential medical news, veterinary expertise, and insights on pet care products and ...

Basel: Roche has announced that the European Commission (EC) has approved a label extension for Evrysdi (risdiplam) to ...

Dr. Tejal Aslesh Tailor is an accomplished neuroscientist and molecular biologist with years of expertise in preclinical ...

In the first part of this series, we explored how early genetic screening and gene therapy transform the lives of newborns ...

The European Commission (EC) has approved a label extension for Evrysdi® (risdiplam) to include a new, room-temperature ...

The global sales of rare neurological disease treatment is estimated to be worth USD 19.95 billion in 2025 and anticipated to reach a value of USD 40.67 billion by 2035. Sales are projected to rise at ...

Physiotherapy, is essential for cancer patients to improve physical function, quality of life, and overall health.